BioNexus Gene Lab Stock (NASDAQ:BGLC)

Revenue Financials Chart

Previous Close

$2.88

52W Range

$2.01 - $8.40

50D Avg

$3.04

200D Avg

$3.64

Market Cap

$4.87M

Avg Vol (3M)

$626.55K

Beta

1.76

Div Yield

-

BGLC Company Profile

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

MY

Employees

30

IPO Date

Jan 08, 2021

Website

BGLC Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 24
Indonesia	$138.30K
Singapore	$572.03K
Sri Lanka	$459.00K

Fiscal year ends in Dec 24 | Currency in USD

BGLC Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$9.51M	$9.77M	$10.93M
Operating Income	$-1.57M	$-2.59M	$-291.18K
Net Income	$-1.60M	$-2.63M	$-355.97K
EBITDA	$-1.57M	$-2.49M	$-185.76K
Basic EPS	$-0.09	$-0.17	$-0.02
Diluted EPS	$-0.09	$-0.17	$-0.02

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

Ticker	Company
FUL	H.B. Fuller Company
GEVO	Gevo, Inc.
OEC	Orion Engineered Carbons S.A.
ALTO	Alto Ingredients, Inc.
SNES	SenesTech, Inc.
IOSP	Innospec Inc.
BCPC	Balchem Corporation
NEU	NewMarket Corporation
PRM	Perimeter Solutions, SA
CRKN	Crown ElectroKinetics Corp.
LOOP	Loop Industries, Inc.